Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

D-dimer is a fibrin degradation product encompassing multiple cross-linked D domains
and/or E domains present in the original fibrinogen molecule, whose generation is only …

Complement C3 activation contributes to COVID-19 pathology, and C3 targeting has
emerged as a promising therapeutic strategy. We provide interim data from ITHACA, the first …

The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

D-dimers reflect a breakdown product of fibrin. The current narrative review outlines how D-
dimers can arise in normal individuals, as well as in patients suffering from a wide range of …

BACKGROUND Evidence regarding the safety and efficacy of anticoagulant
thromboprophylaxis among pediatric patients hospitalized for coronavirus disease 2019 …

The clinical course of coronavirus disease 2019 (COVID-19) is often complicated by the
onset of venous thrombosis and thromboembolism (VTE), encompassing also pulmonary …

Background Venous thromboembolism (VTE) remains the third leading cause of acute
cardiovascular syndrome following myocardial infarction and ischemic stroke. The global …

Background This study assessed the impact of the COVID-19 epidemic on overall
hospitalizations for pulmonary embolism (PE) in France in comparison with previous years …

Background This study analyzed complication rates following primary elective total joint
arthroplasty (TJA) in patients who subsequently contracted COVID-19. Methods A large …